Which Weight Management Treatment Suits Your Lifestyle?
Switch to Wegovy vs Mounjaro: Understanding the Core Differences
When you switch to Wegovy, you're choosing a targeted GLP-1 receptor agonist that mimics your body's natural fullness hormone. This prescription-only medicine works specifically on appetite centres in your brain, promoting feelings of satiety after smaller meals. Mounjaro, by contrast, employs a dual mechanism targeting both GIP and GLP-1 receptors, offering a broader hormonal approach to weight management alongside diet and exercise.
The decision to switch to Wegovy versus Mounjaro often comes down to individual response and practical considerations. Wegovy follows a structured 5-dose escalation from 0.25mg to 2.4mg over 16 weeks, whilst Mounjaro uses 6 dose levels from 2.5mg to 15mg. Both treatments require weekly injections using pre-filled pens, and both are available through EverydayMeds' streamlined online service with comprehensive prescriber support to guide your choice.
Wegovy vs Mounjaro Pricing: Transparent Cost Comparison
Understanding the financial commitment when you switch to Wegovy helps inform your treatment decision. Our Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers can apply code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 to reach these competitive prices.
For those considering whether to switch to Wegovy or choose Mounjaro, our bundle options provide convenient multi-month supply. The Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks of treatment, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. Both Wegovy and Mounjaro are available from EverydayMeds, allowing our prescribers to recommend the most suitable option based on your clinical assessment and individual circumstances.
Clinical Evidence: Why Patients Switch to Wegovy
The decision to switch to Wegovy is often supported by robust clinical evidence from the STEP trial programme. In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average of ~clinically studied weight loss at 68 weeks in the landmark STEP 1 study (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight management with ~15.2% average weight loss maintained at 2 years.
Additionally, the SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events among participants, highlighting Wegovy's broader health benefits beyond weight management. When patients switch to Wegovy from other approaches, they're choosing a treatment with extensive real-world evidence and long-term safety data, prescribed alongside a reduced-calorie diet and increased physical activity.
How Wegovy Works: The Science Behind Your Switch to Wegovy
When you switch to Wegovy, you're harnessing the power of semaglutide, a GLP-1 receptor agonist that closely mimics your body's natural incretin hormones. This prescription-only medicine works primarily in your brain's appetite control centres, reducing hunger signals and promoting feelings of fullness after smaller portions. Unlike some weight management approaches, Wegovy specifically targets the physiological mechanisms that regulate food intake and satiety. The medication also slows gastric emptying, helping you feel satisfied for longer periods after meals. This multi-faceted approach explains why patients who switch to Wegovy often report reduced food cravings and a more sustainable relationship with eating patterns.
Seamless Ordering: Your Path to Switch to Wegovy
Starting your journey to switch to Wegovy through EverydayMeds takes just minutes with our streamlined online process. Complete our 3-minute clinical assessment covering your medical history, current medications, and weight management goals, ensuring our prescribers have comprehensive information for your consultation. Our qualified prescribers review applications within standard 3 working days, or choose express 24-hour review for faster processing. Once approved, your Wegovy is dispatched via next-day delivery using cold-chain, temperature-controlled logistics to maintain medication integrity. Our GPhC #9012878 registered pharmacy ensures full compliance with UK regulations whilst providing the convenience of direct-to-door delivery.
Storage and Practical Considerations for Your Wegovy Switch
One significant advantage when you switch to Wegovy is its superior storage flexibility compared to Mounjaro. Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day limit. This makes Wegovy particularly suitable for frequent travellers or those with variable schedules. The FlexTouch pen system provides intuitive injection with a clear dose counter, and the mandatory dose escalation schedule from 0.25mg to 2.4mg helps minimise potential side effects whilst optimising treatment response. Store unused pens in your fridge at 2-8°C, and never freeze or shake the medication.
Why Healthcare Professionals Recommend the Switch to Wegovy
Medical professionals often recommend patients switch to Wegovy due to its established efficacy profile and practical advantages over alternative treatments. The structured dose escalation protocol allows for personalised titration based on individual tolerance and response, whilst the once-weekly injection schedule improves adherence compared to daily medications. Wegovy's extensive clinical trial data spanning multiple patient populations provides confidence in long-term safety and effectiveness.
The decision to switch to Wegovy is particularly compelling for patients who value treatment flexibility and proven cardiovascular benefits. Our clinical team at EverydayMeds works closely with patients throughout their treatment journey, providing ongoing support and monitoring to optimise outcomes and address any concerns that arise during therapy.
Complete Your Switch to Wegovy with EverydayMeds Today
Ready to switch to Wegovy with confidence and expert support? Start your clinical assessment now and join thousands of patients who've chosen EverydayMeds for their weight management journey. New customers can apply discount code FIRST40 at checkout, whilst returning patients benefit from DOSE25 for ongoing savings. Our comprehensive service includes prescriber consultation, next-day delivery, and ongoing clinical support throughout your treatment. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your assessment, or contact our clinical team for personalised guidance on whether Wegovy or Mounjaro best suits your individual needs. Both treatments are available through our streamlined online service, backed by our GPhC #9012878 registration and commitment to exceptional patient care.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
